If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

Share Price is delayed by 15 minutes
Get Live Data
1,046.00    -6.00 (-0.57%)
Bid:
1,045.50
Ask:
1,047.00
Spread: 1.50 (0.143%)
Market Cap: £5.12b
BAB Live PriceLast checked at - London Stock Exchange

Intraday Babcock Share Chart

Contract Award

29 Jun 2017 07:00

RNS Number : 4884J
Babcock International Group PLC
29 June 2017
 

29 June 2017

 

 

Babcock International Group PLC (Babcock or the Group)

Babcock awarded new contract to operate new aircraft fleet for Norwegian Health Service

 

 

Babcock, the engineering services company, has been awarded a new contract by the Norwegian Government to provide communities across Norway with vital air ambulance support.

 

Initially for six years with options to extend by a further five years, the contract is worth around £500 million for the full 11 years. It will see Babcock operate 11 specialist fixed-wing aircraft from summer 2019, providing thousands of patients with access to specialist healthcare centres across Norway. The aircraft will be secured on leases which match the contract period, including option years.

 

Operating from seven bases, the aircraft will be fitted out with custom-designed medical interiors, featuring hospital-standard equipment. They will form a key part of Norway's overall healthcare infrastructure, where hospitals are increasingly developing specialist skills and capabilities for particular areas of treatment.

 

This award continues the good progress made in building Babcock's international presence and demonstrates the ongoing demand for the Group's services in new markets.

 

Babcock Chief Executive Archie Bethel said:

 

"I am delighted that Babcock has been selected to deliver this critical aspect of Norway's healthcare infrastructure. This will be the first time we have worked in Norway, but the contract will draw on our experience of delivering air ambulance care across Scandinavia and around the world.

 

"Our emergency medical services (EMS) aviation business has grown strongly in recent years, and this latest win in a new country underlines the increasing demand for our air ambulance services. As hospitals become specialised centres of medical excellence, it is more important than ever to have a trusted system in place to transport patients swiftly and safely, with expert care, to where they can receive the best possible medical attention."

 

Babcock has extensive experience of running Helicopter Emergency Services (HEMS) across countries including Italy, France, Spain, Portugal, Sweden, Finland as well as Australia and the UK.

 

Babcock's fleet of over 330 Emergency Service aircraft, operated by highly experienced crews and supported by skilled staff, executes around 90,000 missions each year, providing critical air ambulance, search and rescue, firefighting, police and civil protection services. The Group also operates over 50 helicopters serving the oil and gas sector.

 

 

Ends

 

 

 

 

 

Enquiries

 

Babcock International Group PLC

 

020 7355 5300

Franco Martinelli

Kate Hill

FTI Consulting

020 3727 1340

Andrew Lorenz

Nick Hasell

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTSEFFMAFWSEDM
Date   Source Headline
11th Jul 20237:00 amRNSDate of publication of FY23 preliminary statement
24th May 20238:54 amRNSDirectorate Change
20th Apr 20237:00 amRNSFY23 post close update and Type 31 contract update
1st Mar 20237:00 amRNSDisposal programme successfully concluded
15th Feb 20239:09 amRNSBabcock awarded contract to operate Skynet
2nd Feb 20238:13 amRNSDirectorate Change
20th Dec 202212:54 pmRNSStandard & Poor credit rating upgrade
9th Dec 20229:29 amRNSHolding(s) in Company
8th Dec 20229:06 amRNSHolding(s) in Company
22nd Nov 20227:00 amRNSHalf-year Report
9th Nov 20224:48 pmRNSHolding(s) in Company
3rd Nov 202212:13 pmRNSRestatement of pass-through revenue for HY22
3rd Nov 202211:08 amRNSRestatement of H1 2022 Results
21st Oct 20228:05 amRNSContract Win
18th Oct 20229:00 amRNSDirector appointment
13th Oct 202210:41 amRNSHolding(s) in Company
26th Sep 20224:00 pmRNSResult of AGM
26th Sep 20227:00 amRNSAGM Trading Update
12th Sep 20221:25 pmRNSNotice of AGM
25th Aug 202210:23 amRNSDirectorate Change
15th Aug 20225:14 pmRNSNotice of Availability
2nd Aug 20221:09 pmRNSDirector/PDMR Shareholding
29th Jul 20224:02 pmRNSCORRECTION: Full year results year ended 31.03.22
28th Jul 20227:00 amRNSFull year results for the year ended 31 March 2022
19th Jul 20227:00 amRNSSale of part of aerial emergency services business
20th Apr 202212:26 pmRNSDirector Declaration
6th Apr 202210:29 amRNSDirector Declaration
5th Apr 20229:16 amRNSHolding(s) in Company
28th Mar 202211:24 amRNSHolding(s) in Company
14th Mar 202210:00 amRNSCompletion of acquisition of NSM joint venture
7th Mar 202210:26 amRNSHolding(s) in Company
2nd Mar 20229:23 amRNSHolding(s) in Company
25th Feb 20227:00 amRNSTrading Update
15th Feb 20227:00 amRNSBabcock to acquire balance of Australian naval JV
10th Feb 202210:05 amRNSHolding(s) in Company
10th Feb 20227:00 amRNSCompletion of sale of stake in AirTanker Holdings
4th Feb 202210:00 amRNSDirectorate Change
2nd Feb 20228:58 amRNSHolding(s) in Company
24th Jan 202211:04 amRNSDirector/PDMR Shareholding
13th Jan 20228:48 amRNSHolding(s) in Company
10th Jan 20221:18 pmRNSHolding(s) in Company
6th Jan 20227:00 amRNSDirector Appointment
24th Dec 20217:00 amRNSCompletion of the sale of UK Power business
14th Dec 20214:08 pmRNSHolding(s) in Company
7th Dec 20217:00 amRNSHalf-year Report
6th Dec 202110:20 amRNSRestatement of results for HY ended 30 Sept 2020
16th Nov 202111:31 amRNSHolding(s) in Company
8th Nov 20214:44 pmRNSHolding(s) in Company
21st Oct 20217:00 amRNSSale of Frazer-Nash and half year trading update
24th Sep 20213:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.